OSE Immunotherapeutics Receives Notice of Allowance for New Patent by U.S. Patent and Trademark Office that Further Strengthens Intellectual Property Portfolio Around Tedopi® in Immuno-Oncology Applications

The new patent extends the U.S. protection of Tedopi® to several combinations of  neoepitopes…